Selective serotonin reuptake inhibitors

DRUG5 trials

Sponsors

Samsung Medical Center, Faculdade de Medicina do ABC, All India Institute of Medical Sciences, Bhubaneswar, Sir Run Run Shaw Hospital, Asad Ullah Jan

Conditions

Major Depressive DisorderMenopauseOveractive BladderPTSDPTSD - Post Traumatic Stress Disorder

Phase 4

Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients

CompletedNCT00902421

Samsung Medical CenterOveractive Bladder

Start: 2007-01-31End: 2009-07-31Updated: 2010-08-26

Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder

CompletedNCT05181527

All India Institute of Medical Sciences, BhubaneswarMajor Depressive Disorder

Start: 2022-02-10End: 2023-11-30Updated: 2023-12-22

Unknown Phase

Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

CompletedNCT05050981

Faculdade de Medicina do ABCMenopause

Start: 2021-03-01End: 2022-02-28Updated: 2022-09-10

Prospective Clinical Cohort Study of Depression

Sir Run Run Shaw HospitalMajor Depressive Disorder

Start: 2023-06-15End: 2024-05-20Target: 300Updated: 2023-10-27

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder

CompletedNCT06955845

Asad Ullah JanPTSD, PTSD - Post Traumatic Stress Disorder

Start: 2025-05-06End: 2025-12-31Updated: 2026-05-07

Related Papers

Predicting the Treatment Response of Patients With Major Depressive Disorder to Selective Serotonin Reuptake Inhibitors Using Machine Learning Techniques and EEG Functional Connectivity Features

Depression and Anxiety2025-01-012 citations

Early augmentation therapy with dextromethorphan in mild to moderate major depressive disorder: A group sequential, response adaptive randomized controlled trial.

2024-11-081 citations

Repurposing of dextromethorphan as an adjunct therapy in patients with major depressive disorder: a randomised, group sequential adaptive design, controlled clinical trial protocol

BMJ Open2024-04-013 citations